![]() Reed told News On 6 that the state is fighting to get more treatments by reaching out to the White House on a weekly basis. "We get these on weekly allocations, but typically not enough to meet Oklahoma's needs," said Oklahoma Health Commissioner, Keith Reed. Of course, this isn't just an issue at Tulsa ER and Hospital it's a statewide problem. The hospital said it's always had criteria in place when it comes to deciding who receives the monoclonal treatment. Mark Blubaugh, the Medical Director for Tulsa ER & Hospital. "We just had 24 delivered, where we were doing 15 to 30 infusions a day. "We have to prioritize the use of that for the most at-risk patients," said Dr. On January 10, the hospital staff said they had five doses left of Sotrovimab, which is the only treatment effective against the Omicron variant.įortunately, a new shipment came in January 11, however doctors worry it's not enough. Tulsa ER & Hospital in Tulsa Hills nearly ran out of monoclonal antibodies this week. However, with demand now higher than supply, treatments are more difficult to come by. When it comes to treating COVID-19, monoclonal antibodies have shown success.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |